<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN" "http://jats.nlm.nih.gov/publishing/1.1d1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">AJOD</journal-id>
<journal-title-group>
<journal-title>African Journal of Disability</journal-title>
</journal-title-group>
<issn pub-type="ppub">2223-9170</issn>
<issn pub-type="epub">2226-7220</issn>
<publisher>
<publisher-name>AOSIS</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">AJOD-15-1766</article-id>
<article-id pub-id-type="doi">10.4102/ajod.v15i0.1766</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pulmonary rehabilitation in severe chronic obstructive pulmonary disease: Is there any benefit?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1599-408X</contrib-id>
<name>
<surname>Sabah</surname>
<given-names>Hala A.E.</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6901-8733</contrib-id>
<name>
<surname>Mohammed</surname>
<given-names>Rehab</given-names>
</name>
<xref ref-type="aff" rid="AF0002">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-1256-0101</contrib-id>
<name>
<surname>Rashad</surname>
<given-names>Samia M.</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<aff id="AF0001"><label>1</label>Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Ain Shams University, Cairo, Egypt</aff>
<aff id="AF0002"><label>2</label>Department of Chest Disease, Faculty of Medicine, Ain Shams University, Cairo, Egypt</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><bold>Corresponding author:</bold> Hala Sabah, <email xlink:href="halams@med.asu.edu.eg">halams@med.asu.edu.eg</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>14</day><month>01</month><year>2026</year></pub-date>
<pub-date pub-type="collection"><year>2026</year></pub-date>
<volume>15</volume>
<elocation-id>1766</elocation-id>
<history>
<date date-type="received"><day>01</day><month>06</month><year>2025</year></date>
<date date-type="accepted"><day>12</day><month>11</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2026. The Authors</copyright-statement>
<copyright-year>2026</copyright-year>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>Licensee: AOSIS. This work is licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.</license-p>
</license>
</permissions>
<abstract>
<sec id="st1">
<title>Background</title>
<p>Pulmonary rehabilitation (PR) is a key pillar in the management of chronic obstructive pulmonary disease (COPD). Nevertheless, adherence to PR is low, especially in advanced COPD patients who frequently suffer from poor health and severely impaired functional capacity.</p>
</sec>
<sec id="st2">
<title>Objectives</title>
<p>The aim of this study is to evaluate whether a home-based PR programme could benefit severe COPD patients&#x2019; physical and respiratory functions.</p>
</sec>
<sec id="st3">
<title>Method</title>
<p>This is a prospective interventional study in which stage IV COPD patients received a home-based, customised PR programme for 3 weeks. Baseline Barthel functional scale, dyspnoea grade, COPD assessment test (CAT) score and 6-min walking test (6MWT) were all assessed before and after the programme.</p>
</sec>
<sec id="st4">
<title>Results</title>
<p>Forty patients were enrolled; their mean age was 66.43 &#x00B1; 2.99 years. A significant reduction in dyspnoea severity was observed, with 40&#x0025; of patients reaching grade I and 37.5&#x0025; becoming grade II, while on the other hand, grade III, the most prevalent pre-PR grade, was reduced (7.5&#x0025;) at the end of the 3 weeks. The mean CAT score, Barthel score and 6MWT distance showed a highly significant (HS) reduction (<italic>p</italic> &#x003C; 0.001).</p>
</sec>
<sec id="st5">
<title>Conclusion</title>
<p>Home-based, low-intensity PR programmes could be beneficial in severe COPD and can serve as an alternative in case of difficulties in attending clinical settings.</p>
</sec>
<sec id="st6">
<title>Contribution</title>
<p>Home-based PR programmes may ensure long-term adherence to rehabilitation, which decreases patients&#x2019; disabilities and facilitates a shift towards positive lifestyle changes.</p>
</sec>
</abstract>
<kwd-group>
<kwd>pulmonary rehabilitation</kwd>
<kwd>PR</kwd>
<kwd>severe COPD</kwd>
<kwd>home-based</kwd>
<kwd>physical exertion</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Funding information</bold> The authors received no financial support for the research, authorship and/or publication of this article.</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec id="s0001">
<title>Introduction</title>
<p>Chronic obstructive pulmonary disease (COPD) is a diverse lung condition marked by chronic respiratory symptoms because of airway abnormalities, ending in persistent and often worsening airflow limitation (Agusti &#x0026; Vogelmeier <xref ref-type="bibr" rid="CIT0001">2023</xref>). Its management has multiple approaches combining medical therapy with pulmonary rehabilitation (PR) associated with lifestyle modifications (Venkatesan <xref ref-type="bibr" rid="CIT0033">2024</xref>).</p>
<p>Patients with COPD tend to be less physically active compared to individuals of the same age group. This inactivity is often driven by a growing fear of physical exertion. As a result, their physical capabilities decline, particularly in areas such as endurance, coordination and balance (Hanania &#x0026; O&#x2019;Donnell <xref ref-type="bibr" rid="CIT0014">2019</xref>). In addition, the muscles in their lower limbs undergo atrophy, characterised by a reduction in muscle fibre size and a decrease in mitochondrial density. This loss of mitochondria, which are crucial for energy production, contributes to further muscular deconditioning and weakness (Henrot et al. <xref ref-type="bibr" rid="CIT0016">2023</xref>).</p>
<p>All these lead to a decline in lung function and recurrent exacerbations, which are common in patients with COPD that end with hospital readmission and a high socioeconomic burden (Hurst et al. <xref ref-type="bibr" rid="CIT0019">2020</xref>; Tachkov et al. <xref ref-type="bibr" rid="CIT0032">2017</xref>).</p>
<p>The health and social consequences of COPD underscore the importance of implementing cost-effective interventions and secondary prevention strategies to reduce its side effects. In this context, engaging in physical activity and exercise-based interventions is a cost-effective approach, offering significant improvements in quality of life (Ramos et al. <xref ref-type="bibr" rid="CIT0027">2019</xref>).</p>
<p>Pulmonary rehabilitation, which includes structured exercise training, is recognised as a cornerstone of COPD management (Evans &#x0026; Steiner <xref ref-type="bibr" rid="CIT0010">2017</xref>). Experts emphasise that PR provides broad benefits across all stages of COPD, even in the presence of multiple comorbidities, and it improves various health-related outcomes (Agusti &#x0026; Vogelmeier <xref ref-type="bibr" rid="CIT0001">2023</xref>, Houben-Wilke et al. <xref ref-type="bibr" rid="CIT0017">2017</xref>), resulting in exacerbation and hospitalisation reduction (Shu et al. <xref ref-type="bibr" rid="CIT0030">2021</xref>). However, maintaining physically active behaviours and adherence to such programmes after completing PR remains low and poses a significant challenge, particularly in patients with severe COPD, as they struggle with poor health and multiple comorbidities. So the gains achieved during PR often diminish within 6&#x2013;12 months after the programme ends (Blindenbach et al. <xref ref-type="bibr" rid="CIT0004">2017</xref>; Malaguti et al. <xref ref-type="bibr" rid="CIT0025">2021</xref>). This causes muscular atrophy and leads to limitations in physical functioning, endurance and activity (Hsieh, Yang &#x0026; Tsai <xref ref-type="bibr" rid="CIT0018">2016</xref>).</p>
<p>Therefore, a home-based programme is another method of integrating PR into daily living patterns and may facilitate adherence as an alternative to removing most of the limitations.</p>
<p>It enhances patients&#x2019; self-confidence, breaks down &#x2018;psychological barriers&#x2019; and promotes long-term adherence to healthier behaviours (Meshe <xref ref-type="bibr" rid="CIT0026">2023</xref>). By facilitating a shift towards positive lifestyle changes, it also helps to reduce financial burdens. Because rehabilitation programmes are designed around everyday activities, it is easy to simplify, explain and supervise this therapy (Yohannes et al. <xref ref-type="bibr" rid="CIT0034">2021</xref>).</p>
<p>Recent studies have demonstrated that implementing a home-based rehabilitation programme can effectively maintain and enhance the self-confidence and quality of life of patients with COPD, in comparison to traditional rehabilitation (Belloumi et al. <xref ref-type="bibr" rid="CIT0002">2024</xref>).</p>
<p>So, we conducted our study to assess the effectiveness of a home-based PR programme in patients with severe COPD and whether it provides a significant benefit to physical and respiratory functions.</p>
</sec>
<sec id="s0002">
<title>Research methods and design</title>
<sec id="s20003">
<title>Patients</title>
<sec id="s30004">
<title>Study design</title>
<p>This was a prospective interventional study, approved by the Research Ethics Committee FMASU (R 264/2024), and registered with the PACTR (Pan African Clinical Trial Registry) with registration number PACTR202502532021451.</p>
</sec>
</sec>
<sec id="s20005">
<title>Patients&#x2019; recruitment</title>
<p>The study was conducted between November 2024 and January 2025 and included clinically stable COPD patients (&#x2265;60 years) of both sexes who were stage IV, according to the updated Global Initiative for COPD (GOLD-2024) criteria (Agusti &#x0026; Vogelmeier <xref ref-type="bibr" rid="CIT0001">2023</xref>), and recruitment was performed from the rehabilitation clinic at the authors&#x2019; institution.</p>
<p>We excluded patients with (1) psychiatric disease, (2) malignancy or immunologic diseases reported in their history or investigation, and (3) respiratory exacerbation requiring hospital admission during the inclusion period.</p>
</sec>
<sec id="s20006">
<title>Treatment group</title>
<p>A total of 47 patients with COPD were enrolled and 40 of them completed the study. Before enrolment, an explanation of the study was performed and written consent was obtained. Then they received a home-based exercise programme after training on this programme by the therapist.</p>
</sec>
<sec id="s20007">
<title>Pulmonary rehabilitation programme intervention details</title>
<sec id="s30008">
<title>Initial assessment and baseline measures</title>
<p>All participants underwent the following baseline evaluations prior to initiation of the PR programme:</p>
<list list-type="bullet">
<list-item><p>Full medical history and clinical examination</p></list-item>
<list-item><p>Baseline oxygen saturation (SpO<sub>2</sub>) at rest</p></list-item>
<list-item><p>Baseline diagnostic spirometry (pre-bronchodilator) (Agusti &#x0026; Vogelmeier <xref ref-type="bibr" rid="CIT0001">2023</xref>)</p></list-item>
<list-item><p>Barthel Index for functional status (Fi <xref ref-type="bibr" rid="CIT0011">1965</xref>)</p></list-item>
<list-item><p>Modified Medical Research Council (mMRC) dyspnoea scale (Bestall et al. <xref ref-type="bibr" rid="CIT0003">1999</xref>)</p></list-item>
<list-item><p>COPD assessment test (CAT) score (Jones et al. <xref ref-type="bibr" rid="CIT0020">2009</xref>)</p></list-item>
<list-item><p>6-Minute walking test (6MWT) (Sciurba &#x0026; Slivka <xref ref-type="bibr" rid="CIT0029">1998</xref>)</p></list-item>
</list>
<p>These assessments were conducted between 8:00 and 10:00 by a multidisciplinary team, including a chest physician and rehabilitation consultant. All patients underwent regular nutritional status assessments and were provided with personalised advice by a qualified clinical dietitian (Geerars-van der Veen et al. <xref ref-type="bibr" rid="CIT0012">2024</xref>).</p>
</sec>
<sec id="s30009">
<title>Rehabilitation programme description</title>
<p>A personalised, home-based multidimensional PR programme was developed in line with ERS/ATS guidelines (Rochester et al. <xref ref-type="bibr" rid="CIT0028">2015</xref>), tailored to each patient&#x2019;s physical capabilities and medical status. The programme began only after optimising the medical treatment.</p>
<p><bold>Frequency and duration:</bold></p>
<list list-type="bullet">
<list-item><p>Sessions were prescribed 7 times per week, with at least 15 sessions over 3 weeks.</p></list-item>
<list-item><p>Each session lasted approximately 45&#x2013;60 min, including warm-up, main exercise set and cool-down.</p></list-item>
<list-item><p>Patients received weekly video or phone consultations to adjust intensity and monitor progress.</p></list-item>
</list>
<p><bold>Intensity prescription and progression criteria:</bold></p>
<list list-type="bullet">
<list-item><p>Exercise intensity was guided using the (mMRC) dyspnoea scale and Rate of Perceived Exertion (RPE), targeting RPE 4&#x2013;6 (moderate to somewhat hard).</p></list-item>
<list-item><p>Heart rate was monitored with a pulse oximeter, aiming for 50&#x0025; &#x2013; 70&#x0025; of estimated HRR (Heart Rate Reserve).</p></list-item>
<list-item><p>Progression by, the ability to complete current exercise set with RPE &#x003C; 4, No desaturation events (SpO<sub>2</sub> &#x003C; 88&#x0025;), No reports of increased dyspnoea or fatigue during the session.</p></list-item>
</list>
<p><bold>Exercise components:</bold> The programme included the following components, using minimal or no equipment for feasibility:</p>
<list list-type="bullet">
<list-item><p>Warm-up and stretching exercises (5&#x2013;10 min).</p></list-item>
<list-item><p>Active range of motion (AROM): exercises for upper and lower limbs, shoulder circles, elbow flexion and extension, wrist rotations and hip, knee, and ankle movements. Two sets with 10&#x2013;12 repetitions per joint (rest: 30 s between sets).</p></list-item>
<list-item><p>Strengthening exercises: using light dumbbells 1 kg &#x2013; 2 kg or resistance bands, bicep curls, shoulder presses, seated leg extensions and heel raises, 2 sets with 8&#x2013;10 repetitions (rest: 1 min between sets).</p></list-item>
<list-item><p>Endurance training: brisk walking, progressive increase weekly (goal: 10&#x2013;30 min based on baseline 6MWT and tolerance).</p></list-item>
<list-item><p>Respiratory exercises: diaphragmatic breathing, pursed-lip breathing, chest expansion and respiratory muscle training (with incentive spirometer or balloon blowing 5&#x2013;10 repetitions each).</p></list-item>
<list-item><p>Balance and gait training: Trunk&#x2013;abdominal exercises, seated marches (20 repetitions), pelvic tilts (10 repetitions), 2 sets, single-leg stand (hold 10&#x2013;15 sec per leg, 3 repetitions), heel-to-toe walking (10 steps), 2 sets.</p></list-item>
<list-item><p>Postural drainage uses gravity-assisted positioning to mobilize bronchial secretions from peripheral to central airways, with patient positioning based on the affected lung segments and maintained for 5&#x2013;15 min. This is followed by effective coughing, involving deep inhalation, breath-holding, and a forceful, controlled cough to expel secretions.</p></list-item>
<list-item><p>Relaxation techniques: 5&#x2013;10 min of progressive muscle relaxation (post-exercise) and guided breathing.</p></list-item>
</list>
<p><bold>Safety instructions:</bold> Patients received both oral and written safety guidelines for home-based exercises, including:</p>
<list list-type="bullet">
<list-item><p>Clear instructions to stop exercise if SpO<sub>2</sub> drops below 88&#x0025;, or if they experience chest pain, dizziness or severe shortness of breath.</p></list-item>
<list-item><p>All participants were advised to exercise in well-ventilated areas and keep a phone nearby in case of emergency.</p></list-item>
<list-item><p>Adequate hydration and, for those with low BMI, a high-protein diet.</p></list-item>
</list>
<p><bold>Adherence monitoring:</bold> Adherence was defined a priori as completing at least 30 min of physical activity per day on five or more days per week, with a minimum of 150 min weekly. Patients maintained daily logbooks recording:</p>
<list list-type="bullet">
<list-item><p>Duration and type of exercise</p></list-item>
<list-item><p>RPE</p></list-item>
<list-item><p>Any symptoms experienced</p></list-item>
</list>
<p>Weekly follow-up was conducted via phone or WhatsApp, where patients reported on their performance and barriers to adherence.</p>
<p><bold>Equipment used:</bold> Minimal home-based equipment was used:</p>
<list list-type="bullet">
<list-item><p>Resistance bands or dumbbells</p></list-item>
<list-item><p>Incentive spirometers or balloons for breathing exercises</p></list-item>
<list-item><p>Pulse oximeter</p></list-item>
<list-item><p>Chairs for seated and support-based exercises</p></list-item>
</list>
<p><bold>Adverse events monitoring:</bold></p>
<list list-type="bullet">
<list-item><p>Patients were instructed to report any falls, significant desaturation episodes (SpO<sub>2</sub> &#x003C; 88&#x0025; for &#x003E; 30 s) or COPD exacerbations.</p></list-item>
<list-item><p>Weekly safety checks were part of the follow-up protocol.</p></list-item>
<list-item><p>No serious adverse events were reported. Minor symptoms included temporary muscle soreness (<italic>n</italic> = 6), transient mild dyspnoea (<italic>n</italic> = 4) and one case of a missed session because of an unrelated viral illness.</p></list-item>
</list>
</sec>
</sec>
<sec id="s20010">
<title>Post-intervention reassessment</title>
<p>After 3 weeks, the following measures were reassessed to evaluate programme effectiveness.</p>
<p>Primary outcome:</p>
<list list-type="bullet">
<list-item><p>mMRC dyspnoea scale</p></list-item>
<list-item><p>CAT score</p></list-item>
<list-item><p>6MWT</p></list-item>
<list-item><p>Barthel Index</p></list-item>
</list>
<p>Secondary outcome:</p>
<list list-type="bullet">
<list-item><p>SpO<sub>2</sub></p></list-item>
</list>
</sec>
<sec id="s20011">
<title>Sample size</title>
<p>Based on the results of Lan et al. (<xref ref-type="bibr" rid="CIT0022">2018</xref>), with improvement of dyspnoea score after exercise from 5.7 to 4.8, the alpha error was 5&#x0025; and the power of the study was 90&#x0025;; therefore, the required sample size was 40 patients. STATA 10 was the programme used for sample size calculation.</p>
</sec>
<sec id="s20012">
<title>Statistical analysis</title>
<p>The data were gathered, reviewed, coded and input into the Statistical Package for Social Science (IBM SPSS) (IBM Corp. Released 2020. IBM SPSS Statistics for Windows, Version 27.0., Armonk, New York, United States). Quantitative data were expressed as means, standard deviations (s.d.) and ranges for parametric data, while medians and interquartile ranges (IQR) were used for non-parametric data. Qualitative variables were summarised using numbers and percentages.</p>
<p>The Wilcoxon signed-rank test was applied for non-parametric data or when comparing paired ordinal data. A 95&#x0025; confidence interval was used, with a 5&#x0025; margin of error accepted. The <italic>p</italic>-value was interpreted as follows: <italic>p</italic>-value &#x003E; 0.05: Non-significant (NS); <italic>p</italic>-value &#x003C; 0.05: Significant (S); <italic>p</italic>-value &#x003C; 0.01: Highly significant (HS).</p>
</sec>
<sec id="s20013">
<title>Ethical considerations</title>
<p>Ethical clearance to conduct this study was obtained from the Ain Shams University, Faculty of Medicine Research Ethics Committee (No. FMASU R264/ 2024).</p>
</sec>
</sec>
<sec id="s0014">
<title>Results</title>
<p>Forty-seven COPD (GOLD IV) patients were enrolled in the study; 7 of them were excluded because of having respiratory exacerbation with a need for hospital admission during the inclusion period, and 40 patients completed the study. We analysed data from patients at baseline, before the beginning of PR and after 3 weeks of the home-based PR programme.</p>
<sec id="s20015">
<title>Demographics and disease characteristics data</title>
<p>The mean age of the included patients was 66.43 &#x00B1; 2.99 years. The mean disease duration was 8.45 &#x00B1; 3.07 years (<xref ref-type="table" rid="T0001">Table 1</xref>).</p>
<table-wrap id="T0001">
<label>TABLE 1</label>
<caption><p>Demographic data and characteristics of the studied patients (<italic>N</italic> = 40).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Characteristic</th>
<th valign="top" align="center"><italic>n</italic></th>
<th valign="top" align="center">&#x0025;</th>
<th valign="top" align="center">Mean &#x00B1; s.d.</th>
<th valign="top" align="center">Range</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold>Age (years)</bold></td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">66.43 &#x00B1; 2.99</td>
<td align="center">61&#x2013;72</td>
</tr>
<tr>
<td align="left" colspan="5"><bold>Sex</bold></td>
</tr>
<tr>
<td align="left">Female</td>
<td align="center">16</td>
<td align="center">40</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">Male</td>
<td align="center">24</td>
<td align="center">60</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left"><bold>Duration of COPD</bold></td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">8.45 &#x00B1; 3.07</td>
<td align="center">4&#x2013;16</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>s.d., standard deviation; COPD, chronic obstructive pulmonary disease.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s20016">
<title>Baseline assessment of clinical parameters</title>
<p>Baseline assessment of clinical parameters showed that nearly half of the patients (47.5&#x0025;) had dyspnoea grade III, while more than a third (35&#x0025;) had grade II. The mean CAT score was 26.95 &#x00B1; 3.61, the mean Barthel Index score was 17.53 &#x00B1; 1.57, and the mean 6MWT distance was 224.25 &#x00B1; 107.19 metres (<xref ref-type="table" rid="T0002">Table 2</xref>).</p>
<table-wrap id="T0002">
<label>TABLE 2</label>
<caption><p>Studied parameters before pulmonary rehabilitation (<italic>N</italic> = 40).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Studied parameters</th>
<th valign="top" align="center"><italic>n</italic></th>
<th valign="top" align="center">&#x0025;</th>
<th valign="top" align="center">Mean &#x00B1; s.d.</th>
<th valign="top" align="center">Range</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="5">Dyspnoea grade (mMRC)</td>
</tr>
<tr>
<td align="left">Grade 0</td>
<td align="center">0</td>
<td align="center">0.0</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">Grade I</td>
<td align="center">5</td>
<td align="center">12.5</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">Grade II</td>
<td align="center">14</td>
<td align="center">35.0</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">Grade III</td>
<td align="center">19</td>
<td align="center">47.5</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">Grade IV</td>
<td align="center">2</td>
<td align="center">5.0</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">CAT score</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">26.95 &#x00B1; 3.61</td>
<td align="center">20&#x2013;35</td>
</tr>
<tr>
<td align="left">Barthel score (0&#x2013;20)</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">17.53 &#x00B1; 1.57</td>
<td align="center">14&#x2013;20</td>
</tr>
<tr>
<td align="left">FEV1 (L)</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">0.75 &#x00B1; 0.10</td>
<td align="center">0.54&#x2013;0.89</td>
</tr>
<tr>
<td align="left">FEV&#x2081; (&#x0025; predicted)</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">68 &#x00B1; 9</td>
<td align="center">49&#x2013;81</td>
</tr>
<tr>
<td align="left">6MWT SPO<sub>2</sub> at rest (&#x0025;)</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">93.98 &#x00B1; 2.20</td>
<td align="center">90&#x2013;99</td>
</tr>
<tr>
<td align="left">6MWT SPO<sub>2</sub> after (&#x0025;)</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">87.77 &#x00B1; 5.08</td>
<td align="center">79&#x2013;95</td>
</tr>
<tr>
<td align="left">6MWT Distance (m)</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">224.25 &#x00B1; 107.19</td>
<td align="center">50&#x2013;400</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>s.d., standard deviation; mMRC, modified Medical Research Council; CAT, COPD assessment test; FEV1, forced expiratory volume in the first second; 6MWT, six-minute walking test; SPO<sub>2</sub>, oxygen saturation.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s20017">
<title>Comparison of the parameters studied before and after pulmonary rehabilitation</title>
<p>A comparison of the results before and after PR revealed a HS improvement in all assessed parameters. A substantial improvement in dyspnoea severity was observed, with 40&#x0025; of patients reaching grade I and 37.5&#x0025; becoming grade II, while on the other hand, grade III, the most prevalent pre-PR grade was reduced (7.5&#x0025;) at the end of the programme. These findings reflect a significant reduction in dyspnoea severity. The mean CAT score improved to 21.85 &#x00B1; 3.94, showing a HS reduction compared to the pre-PR values. Similar improvements in Barthel score and 6MWT distance (<italic>p</italic> &#x003C; 0.01) were observed (<xref ref-type="table" rid="T0003">Table 3</xref>).</p>
<table-wrap id="T0003">
<label>TABLE 3</label>
<caption><p>Comparison between studied parameters before and after pulmonary rehabilitation treatment.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left" rowspan="2">Studied parameters</th>
<th valign="top" align="center" colspan="4">Before PR<hr/></th>
<th valign="top" align="center" colspan="4">After PR<hr/></th>
<th valign="top" align="center" colspan="2">Test value (<italic>df</italic>)<hr/></th>
<th valign="top" align="center" rowspan="2"><italic>p</italic> -value</th>
</tr>
<tr>
<th valign="top" align="center"><italic>n</italic></th>
<th valign="top" align="center">&#x0025;</th>
<th valign="top" align="center">Mean &#x00B1; s.d.</th>
<th valign="top" align="center">Range</th>
<th valign="top" align="center"><italic>n</italic></th>
<th valign="top" align="center">&#x0025;</th>
<th valign="top" align="center">Mean &#x00B1; s.d.</th>
<th valign="top" align="center">Range</th>
<th valign="top" align="center"><italic>z</italic></th>
<th valign="top" align="center"><italic>t</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Dyspnoea grade (mMRC)</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">25.433<xref ref-type="table-fn" rid="TFN0002">&#x002A;</xref></td>
<td align="center">-</td>
<td align="center">&#x003C; 0.001<break/>HS</td>
</tr>
<tr>
<td align="left">Grade 0</td>
<td align="center">0</td>
<td align="center">0.0</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">6</td>
<td align="center">15.0</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">Grade I</td>
<td align="center">5</td>
<td align="center">12.5</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">16</td>
<td align="center">40.0</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">Grade II</td>
<td align="center">14</td>
<td align="center">35.0</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">15</td>
<td align="center">37.5</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">Grade III</td>
<td align="center">19</td>
<td align="center">47.5</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">3</td>
<td align="center">7.5</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">Grade IV</td>
<td align="center">2</td>
<td align="center">5.0</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">0</td>
<td align="center">0.0</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">CAT score</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">26.95 &#x00B1; 3.61</td>
<td align="center">20&#x2013;35</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">21.85 &#x00B1; 3.94</td>
<td align="center">15&#x2013;30</td>
<td align="center">-</td>
<td align="center">(39) = 16.36</td>
<td align="center">&#x003C; 0.001 HS</td>
</tr>
<tr>
<td align="left">Barthel score</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">17.53 &#x00B1; 1.57</td>
<td align="center">14&#x2013;20</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">18.28 &#x00B1; 0.96</td>
<td align="center">16&#x2013;20</td>
<td align="center">-</td>
<td align="center"><italic>t</italic>(39) = &#x2212;5.27<xref ref-type="table-fn" rid="TFN0001">&#x2020;</xref></td>
<td align="center">&#x003C; 0.001 HS</td>
</tr>
<tr>
<td align="left">6MWT SPO2 at rest (&#x0025;)</td>
<td align="left"></td>
<td align="left"></td>
<td align="center">93.98 &#x00B1; 2.20</td>
<td align="center">90&#x2013;99</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">94.55 &#x00B1; 2.22</td>
<td align="center">91&#x2013;99</td>
<td align="center">-</td>
<td align="center"><italic>t</italic>(39) = &#x2212;2.22<xref ref-type="table-fn" rid="TFN0001">&#x2020;</xref></td>
<td align="center">0.032 S</td>
</tr>
<tr>
<td align="left">6MWT SPO2 after (&#x0025;)</td>
<td align="left"></td>
<td align="left"></td>
<td align="center">87.77 &#x00B1; 5.08</td>
<td align="center">79&#x2013;95</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">89.35 &#x00B1; 4.90</td>
<td align="center">81&#x2013;96</td>
<td align="center">-</td>
<td align="center"><italic>t</italic>(39) = &#x2212;2.08<xref ref-type="table-fn" rid="TFN0001">&#x2020;</xref></td>
<td align="center">0.044 S</td>
</tr>
<tr>
<td align="left">6MWT Distance (m)</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">224.25 &#x00B1; 107.19</td>
<td align="center">50&#x2013;400</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">320.90 &#x00B1; 108.99</td>
<td align="center">100&#x2013;450</td>
<td align="center">-</td>
<td align="center"><italic>t</italic>(39) = &#x2212;8.06<xref ref-type="table-fn" rid="TFN0001">&#x2020;</xref></td>
<td align="center">&#x003C; 0.001 HS</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>Note: <italic>p</italic>-value &#x003C; 0.05: Significant (S); <italic>p</italic>-value &#x003C; 0.01: Highly significant (HS); p-value &#x003E; 0.05.</p></fn>
<fn><p>NS, non-significant; PR, pulmonary rehabilitation; mMRC, modified Medical Research Council; CAT, COPD Assessment Test; 6MWT, six-minute walking test; SPO<sub>2</sub>, oxygen saturation; <italic>df</italic>, degree of freedom.</p></fn>
<fn id="TFN0001"><label>&#x2020;</label><p>, Paired <italic>t</italic>-test.</p></fn>
<fn id="TFN0002"><label>&#x002A;</label><p>, Wilcoxon signed-rank test.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s20018">
<title>Reported adherence</title>
<p>Across the study population, the mean adherence rate &#x00B1; s.d. was 88.2&#x0025; &#x00B1; 7.5&#x0025;, indicating good compliance. Notably, 38 out of 40 participants (95&#x0025;) achieved adherence rates exceeding 75&#x0025;.</p>
</sec>
</sec>
<sec id="s0019">
<title>Discussion</title>
<p>We conducted our study to assess the effectiveness of a home-based PR programme in severe COPD patients and whether it provides a significant benefit to physical and respiratory functions.</p>
<p>It is widely recognised that individuals with COPD tend to be less physically active compared to their peers in the same age group, often because of a heightened fear of physical exertion linked to dyspnoea (Hanania &#x0026; O&#x2019;Donnell <xref ref-type="bibr" rid="CIT0014">2019</xref>). However, participation in physical activity and exercise-based interventions is a cost-effective approach, yielding significant improvements in quality of life (Ramos et al. <xref ref-type="bibr" rid="CIT0027">2019</xref>).</p>
<p>These fears, in association with multiple comorbidities, COPD acute exacerbations and increased financial costs, make the adherence to PR programmes a challenge for these patients, especially in severe COPD cases. This is supported by Belloumi et al. (<xref ref-type="bibr" rid="CIT0002">2024</xref>), who demonstrated that poor adherence negatively affects dyspnoea scores, and by Braeken et al. (<xref ref-type="bibr" rid="CIT0006">2017</xref>), who found that severe acute exacerbations are associated with non-completion of the programme.</p>
<p>Despite all these limitations, multiple studies recommend a long-term rehabilitation programme for persistent results; Lan et al.&#x2019;s (<xref ref-type="bibr" rid="CIT0022">2018</xref>) study proved that the benefits of long periods of PR tend to decline over the years when PR stops, and maintenance of PR is associated with greater benefits. A 2-year follow-up study by Yohannes et al. (<xref ref-type="bibr" rid="CIT0034">2021</xref>) for COPD patients showed that maintained exercise programmes sustain an improvement in anxiety and quality of life. Similarly, the study by Candemir, Erg&#x00FC;n and &#x015E;ahin (<xref ref-type="bibr" rid="CIT0007">2021</xref>) showed clinically maintained improvements in exercise capacity and health-related quality of life after 1 year of PR.</p>
<p>These findings highlight the need for home-based programmes as a possible solution for most of the limitations and a suitable alternative with many benefits. In this context, our results are promising, as we observed that although our patients were severe COPD cases, they showed associated improvements in dyspnoea grade (mMRC), CAT score, Barthel score and 6MWT. The severity of dyspnoea was reduced, with the majority of patients reaching grades I and II (40&#x0025; and 37.5&#x0025;, respectively) compared to the pre-programme assessment when 47.5&#x0025; of them were in grade III category. The CAT score improved significantly from 26.95 &#x00B1; 3.61 to 21.85 &#x00B1; 3.94. This suggests that a maintained PR programme may be associated with positive outcomes, even in GOLD IV patients.</p>
<p>This is similar to Cheng et al. (<xref ref-type="bibr" rid="CIT0009">2014</xref>), who found that patients with severe COPD who followed a PR programme experienced minimal dyspnoea at the end of the study. Exercise training is the preferred method to improve dyspnoea, as it addresses both its psychological and physiological aspects. The improvement in dyspnoea is largely attributed to enhanced tolerance and adaptation to exercise at a muscular and cellular level, particularly involving mitochondria in skeletal muscles, including the primary and accessory respiratory muscles. Furthermore, exercise training enhances cardiac autonomic function and reduces lung hyperinflation (Leite et al. <xref ref-type="bibr" rid="CIT0023">2015</xref>). Our study showed a statistically significant change in SpO<sub>2</sub> after PR, indicating reduced exertional desaturation, which could be clinically relevant in patients with respiratory compromise.</p>
<p>The patients&#x2019; quality of life improved, as indicated by the HS improvement in Barthel score. This is similar to the study by Li et al. (<xref ref-type="bibr" rid="CIT0024">2019</xref>), which involved 414 elderly patients and demonstrated that PR led to significant improvements in exercise capacity and quality of life. The researchers observed that the enhancement in quality of life was linked to a reduced fall risk. It showed that both ageing and chest diseases (e.g. COPD) negatively impact postural control. However, various exercises that enhance physical capacities, sensorimotor strategies, postural stability and respiratory function have been shown to reduce the frequency of falls, even in the absence of balance-specific exercise programmes (Boffino et al. <xref ref-type="bibr" rid="CIT0005">2019</xref>).</p>
<p>Our findings are similar to those of Spielmanns et al. (<xref ref-type="bibr" rid="CIT0031">2023</xref>), who reported that participation in a PR led to significant improvements in the assessed parameters in patients with COPD, regardless of age group, including those over 80 years. Similarly, Belloumi et al. (<xref ref-type="bibr" rid="CIT0002">2024</xref>) found a difference in dyspnoea scores, especially in adherent compared to non-adherent patients.</p>
<p>Our exercise programme was tailored according to each patient&#x2019;s condition, allowing flexibility in selecting the level of exercise intensity, the number of repetitions and the number of sessions per week. Hansen et al. (<xref ref-type="bibr" rid="CIT0015">2020</xref>) state that the ultimate objective of PR is to enhance patient autonomy, improve exercise capacity and reduce the limitations imposed by their respiratory condition, promoting long-term adherence. In our study, the mean adherence was about 95&#x0025;, indicating good compliance and demonstrating a high level of engagement and feasibility of the tailored home-based exercise protocol.</p>
<p>Most of our exercises were low intensity to maximise physiological effects while considering the impact of ageing and the severity of COPD. In addition, long-term adherence is associated with low-intensity training (Gloeckl, Marinov &#x0026; Pitta <xref ref-type="bibr" rid="CIT0013">2013</xref>). Breathing exercises such as diaphragmatic breathing and pursed-lips breathing were recommended for patients unable to engage in physical exercise. These techniques have the potential to improve pulmonary function, exercise endurance, dyspnoea, quality of life and respiratory muscle strength in COPD patients (Ceyhan &#x0026; Tekinsoy <xref ref-type="bibr" rid="CIT0008">2022</xref>; Junita et al. <xref ref-type="bibr" rid="CIT0021">2022</xref>).</p>
<p>Implementing home-based rehabilitation programmes enables physicians to extend care to a larger number of patients than would be possible through traditional rehabilitation centres. This approach supports cost-effective interventions as part of secondary prevention strategies, helping to reduce the risk of developing COPD or experiencing exacerbations, thereby lowering the likelihood of rehospitalisations. These programmes typically involve mild-intensity exercises with adjustable intensity levels to ensure patient safety, build self-confidence and gradually progress to higher intensity aerobic workouts. Home-based rehabilitation is particularly beneficial for patients who face barriers to accessing clinical settings or during pandemics when gatherings are risky or impractical.</p>
<p>A key strength of our study is the inclusion of elderly patients with advanced (severe) COPD, a population that faces significant challenges in maintaining daily activities because of both ageing and the underlying lung disease. Our study provides preliminary evidence that targeting this vulnerable subset of the population with a simple, yet effective, home-based PR programme is a promising approach.</p>
<p>However, our study has some limitations. Although our study included a statistically representative sample size, as determined by an expert statistician at our institution, the relatively small number of participants may still limit the generalisability of the findings. Furthermore, the number of sets and the intensity of exercises were different, tailored according to each patient&#x2019;s ability and fitness. We did not have a comparable control group.</p>
<p>These limitations suggest that our results be interpreted with some caution.</p>
</sec>
<sec id="s0020">
<title>Conclusion</title>
<p>Home-based, low-intensity PR programmes could be beneficial in severe COPD and can serve as an alternative in case of difficulties in attending clinical settings.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<sec id="s20021" sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.</p>
</sec>
<sec id="s20022">
<title>CRediT authorship contribution</title>
<p>Hala A.E. Sabah: Conceptualisation, Methodology, Investigation, Writing &#x2013; original draft, Validation, Data curation, Writing &#x2013; review &#x0026; editing, Funding acquisition. Rehab Mohammed: Conceptualisation, Methodology, Writing &#x2013; original draft, Visualisation, Validation, Supervision, Funding acquisition. Samia M. Rashad: Methodology, Formal analysis, Writing &#x2013; original draft, Visualisation, Validation, Supervision, Funding acquisition. All authors reviewed the article, contributed to the discussion of results, approved the final version for submission and publication, and take responsibility for the integrity of its findings.</p>
</sec>
<sec id="s20023" sec-type="data-availability">
<title>Data availability</title>
<p>The authors declare that all data that support this research article and findings are available in the article and its references.</p>
</sec>
<sec id="s20024">
<title>Disclaimer</title>
<p>The views and opinions expressed in this article are those of the authors and are the product of professional research. It does not necessarily reflect the official policy or position of any affiliated institution, funder, agency or that of the publisher. The authors are responsible for this article&#x2019;s results, findings and content.</p>
</sec>
</ack>
<ref-list id="references">
<title>References</title>
<ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Agusti</surname>, <given-names>A</given-names></string-name>. &#x0026; <string-name><surname>Vogelmeier</surname>, <given-names>C.F</given-names></string-name></person-group>., <year>2023</year>, &#x2018;<article-title>GOLD 2024: A brief overview of key changes</article-title>&#x2019;, <source><italic>Jornal Brasileiro de Pneumologia</italic></source> <volume>49</volume>(<issue>6</issue>), <fpage>e20230369</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.36416/1806-3756/e20230369">https://doi.org/10.36416/1806-3756/e20230369</ext-link></comment></mixed-citation></ref>
<ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Belloumi</surname>, <given-names>N</given-names></string-name>., <string-name><surname>Habouria</surname>, <given-names>C</given-names></string-name>., <string-name><surname>Bachouch</surname>, <given-names>I</given-names></string-name>., <string-name><surname>Mersni</surname>, <given-names>M</given-names></string-name>., <string-name><surname>Chermiti</surname>, <given-names>F</given-names></string-name>. &#x0026; <string-name><surname>Fenniche</surname>, <given-names>S</given-names></string-name></person-group>., <year>2024</year>, &#x2018;<article-title>Feasibility of a home-designed respiratory rehabilitation program for chronic obstructive pulmonary disease</article-title>&#x2019;, <source><italic>Primary Health Care Research &#x0026; Development</italic></source> <volume>25</volume>, <fpage>e7</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S1463423623000324">https://doi.org/10.1017/S1463423623000324</ext-link></comment></mixed-citation></ref>
<ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bestall</surname>, <given-names>J.C</given-names></string-name>., <string-name><surname>Paul</surname>, <given-names>E.A</given-names></string-name>., <string-name><surname>Garrod</surname>, <given-names>R</given-names></string-name>., <string-name><surname>Garnham</surname>, <given-names>R</given-names></string-name>., <string-name><surname>Jones</surname>, <given-names>P.W</given-names></string-name>. &#x0026; <string-name><surname>Wedzicha</surname>, <given-names>J</given-names></string-name></person-group>., <year>1999</year>, &#x2018;<article-title>Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease</article-title>&#x2019;, <source><italic>Thorax</italic></source> <volume>54</volume>(<issue>7</issue>), <fpage>581</fpage>&#x2013;<lpage>586</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/thx.54.7.581">https://doi.org/10.1136/thx.54.7.581</ext-link></comment></mixed-citation></ref>
<ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blindenbach</surname>, <given-names>S</given-names></string-name>., <string-name><surname>Vrancken</surname>, <given-names>J.W</given-names></string-name>., <string-name><surname>Van der Zeijden</surname>, <given-names>H</given-names></string-name>., <string-name><surname>Reesink</surname>, <given-names>H.J</given-names></string-name>., <string-name><surname>Brijker</surname>, <given-names>F</given-names></string-name>., <string-name><surname>Smalbrugge</surname>, <given-names>M</given-names></string-name>. <etal>et al</etal></person-group>., <year>2017</year>, &#x2018;<article-title>Effecten van geriatrische COPD-revalidatie op ziekenhuisopnames en inspanningstolerantie: een retrospectief observationele studie</article-title>&#x2019;, <source><italic>Tijdschrift voor Gerontologie en Geriatrie</italic></source> <volume>48</volume>, <fpage>112</fpage>&#x2013;<lpage>120</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12439-017-0214-8">https://doi.org/10.1007/s12439-017-0214-8</ext-link></comment></mixed-citation></ref>
<ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boffino</surname>, <given-names>C.C</given-names></string-name>., <string-name><surname>Pereira</surname>, <given-names>A.C.A.C</given-names></string-name>., <string-name><surname>Coelho</surname>, <given-names>D.B</given-names></string-name>., <string-name><surname>Xavier</surname>, <given-names>R.F</given-names></string-name>., <string-name><surname>Berto</surname>, <given-names>C.C</given-names></string-name>., <string-name><surname>Da Silva</surname>, <given-names>M</given-names></string-name>. <etal>et al</etal></person-group>., <year>2019</year>, &#x2018;<article-title>Age and disease have a distinct influence on postural balance of patients with COPD</article-title>&#x2019;, <source><italic>COPD: Journal of Chronic Obstructive Pulmonary Disease</italic></source> <volume>16</volume>(<issue>3&#x2013;4</issue>), <fpage>246</fpage>&#x2013;<lpage>253</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/15412555.2019.1634683">https://doi.org/10.1080/15412555.2019.1634683</ext-link></comment></mixed-citation></ref>
<ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Braeken</surname>, <given-names>D.C</given-names></string-name>., <string-name><surname>Spruit</surname>, <given-names>M.A</given-names></string-name>., <string-name><surname>Houben-Wilke</surname>, <given-names>S</given-names></string-name>., <string-name><surname>Smid</surname>, <given-names>D.E</given-names></string-name>., <string-name><surname>Rohde</surname>, <given-names>G.G</given-names></string-name>., <string-name><surname>Wouters</surname>, <given-names>E.F</given-names></string-name>. <etal>et al</etal></person-group>., <year>2017</year>, &#x2018;<article-title>Impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD</article-title>&#x2019;, <source><italic>Respirology</italic></source> <volume>22</volume>(<issue>5</issue>), <fpage>942</fpage>&#x2013;<lpage>949</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/resp.12987">https://doi.org/10.1111/resp.12987</ext-link></comment></mixed-citation></ref>
<ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Candemir</surname>, <given-names>I</given-names></string-name>., <string-name><surname>Erg&#x00FC;n</surname>, <given-names>P</given-names></string-name>. &#x0026; <string-name><surname>&#x015E;ahin</surname>, <given-names>M.E</given-names></string-name></person-group>., <year>2021</year>, &#x2018;<article-title>Maintenance of pulmonary rehabilitation benefits in patients with COPD: Is a structured5-year follow-up program helpful?</article-title>&#x2019; <source><italic>Turkish Journal of Medical Sciences</italic></source> <volume>51</volume>(<issue>6</issue>), <fpage>2915</fpage>&#x2013;<lpage>2923</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3906/sag-2101-245">https://doi.org/10.3906/sag-2101-245</ext-link></comment></mixed-citation></ref>
<ref id="CIT0008"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ceyhan</surname>, <given-names>Y</given-names></string-name>. &#x0026; <string-name><surname>Tekinsoy Kartin</surname>, <given-names>P</given-names></string-name></person-group>., <year>2022</year>, &#x2018;<article-title>The effects of breathing exercises and inhaler training in patients with COPD on the severity of dyspnea and life quality: A randomized controlled trial</article-title>&#x2019;, <source><italic>Trials</italic></source> <volume>23</volume>(<issue>1</issue>), <fpage>707</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13063-022-06603-3">https://doi.org/10.1186/s13063-022-06603-3</ext-link></comment></mixed-citation></ref>
<ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname>, <given-names>S.T</given-names></string-name>., <string-name><surname>Wu</surname>, <given-names>Y.K</given-names></string-name>., <string-name><surname>Yang</surname>, <given-names>M.C</given-names></string-name>., <string-name><surname>Huang</surname>, <given-names>C.Y</given-names></string-name>., <string-name><surname>Huang</surname>, <given-names>H.C</given-names></string-name>., <string-name><surname>Chu</surname>, <given-names>W.H</given-names></string-name>. <etal>et al</etal></person-group>., <year>2014</year>, &#x2018;<article-title>Pulmonary rehabilitation improves heart rate variability at peak exercise, exercise capacity and health-related quality of life in chronic obstructive pulmonary disease</article-title>&#x2019;, <source><italic>Heart &#x0026; Lung</italic></source> <volume>43</volume>(<issue>3</issue>), <fpage>249</fpage>&#x2013;<lpage>255</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.hrtlng.2014.03.002">https://doi.org/10.1016/j.hrtlng.2014.03.002</ext-link></comment></mixed-citation></ref>
<ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Evans</surname>, <given-names>R.A</given-names></string-name>. &#x0026; <string-name><surname>Steiner</surname>, <given-names>M.C</given-names></string-name></person-group>., <year>2017</year>, &#x2018;<article-title>Pulmonary rehabilitation: The lead singer of COPD therapy but not a &#x201C;One-Man Band&#x201D;</article-title>&#x2019;, <source><italic>Chest</italic></source> <volume>152</volume>(<issue>6</issue>), <fpage>1103</fpage>&#x2013;<lpage>1105</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chest.2017.06.040">https://doi.org/10.1016/j.chest.2017.06.040</ext-link></comment></mixed-citation></ref>
<ref id="CIT0011"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fi</surname>, <given-names>M</given-names></string-name></person-group>., <year>1965</year>, &#x2018;<article-title>Functional evaluation: The Barthel index</article-title>&#x2019;, <source><italic>Maryland State Medical Journal</italic></source> <volume>14</volume>, <fpage>61</fpage>&#x2013;<lpage>65</lpage>.</mixed-citation></ref>
<ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Geerars-van der Veen</surname>, <given-names>M</given-names></string-name>., <string-name><surname>Ballemans</surname>, <given-names>J</given-names></string-name>., <string-name><surname>Bongers</surname>, <given-names>A.M</given-names></string-name>., <string-name><surname>Van Loon</surname>, <given-names>A</given-names></string-name>. &#x0026; <string-name><surname>Smit</surname>, <given-names>E.B</given-names></string-name></person-group>., <year>2024</year>, &#x2018;<article-title>Feasibility of a novel geriatric rehabilitation program for people with COPD-induced malnutrition and muscle wasting: A qualitative study</article-title>&#x2019;, <source><italic>Gerontology and Geriatric Medicine</italic></source> <volume>10</volume>, <fpage>23337214241246435</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/23337214241246435">https://doi.org/10.1177/23337214241246435</ext-link></comment></mixed-citation></ref>
<ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gloeckl</surname>, <given-names>R</given-names></string-name>., <string-name><surname>Marinov</surname>, <given-names>B</given-names></string-name>. &#x0026; <string-name><surname>Pitta</surname>, <given-names>F</given-names></string-name></person-group>., <year>2013</year>, &#x2018;<article-title>Practical recommendations for exercise training in patients with COPD</article-title>&#x2019;, <source><italic>European Respiratory Review</italic></source> <volume>22</volume>(<issue>128</issue>), <fpage>178</fpage>&#x2013;<lpage>186</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1183/09059180.00000513">https://doi.org/10.1183/09059180.00000513</ext-link></comment></mixed-citation></ref>
<ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hanania</surname>, <given-names>N.A</given-names></string-name>. &#x0026; <string-name><surname>O&#x2019;Donnell</surname>, <given-names>D.E</given-names></string-name></person-group>., <year>2019</year>, &#x2018;<article-title>Activity-related dyspnea in chronic obstructive pulmonary disease: Physical and psychological consequences, unmet needs, and future directions</article-title>&#x2019;, <source><italic>International Journal of Chronic Obstructive Pulmonary Disease</italic></source> <volume>14</volume>, <fpage>1127</fpage>&#x2013;<lpage>1138</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2147/COPD.S188141">https://doi.org/10.2147/COPD.S188141</ext-link></comment></mixed-citation></ref>
<ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hansen</surname>, <given-names>H</given-names></string-name>., <string-name><surname>Bieler</surname>, <given-names>T</given-names></string-name>., <string-name><surname>Beyer</surname>, <given-names>N</given-names></string-name>., <string-name><surname>Kallemose</surname>, <given-names>T</given-names></string-name>., <string-name><surname>Wilcke</surname>, <given-names>J.T</given-names></string-name>., <string-name><surname>&#x00D8;stergaard</surname>, <given-names>L.M</given-names></string-name>. <etal>et al</etal></person-group>., <year>2020</year>, &#x2018;<article-title>Supervised pulmonary tele-rehabilitation versus pulmonary rehabilitation in severe COPD: A randomised multicentre trial</article-title>&#x2019;, <source><italic>Thorax</italic></source> <volume>75</volume>(<issue>5</issue>), <fpage>413</fpage>&#x2013;<lpage>421</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/thoraxjnl-2019-214246">https://doi.org/10.1136/thoraxjnl-2019-214246</ext-link></comment></mixed-citation></ref>
<ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Henrot</surname>, <given-names>P</given-names></string-name>., <string-name><surname>Dupin</surname>, <given-names>I</given-names></string-name>., <string-name><surname>Schilfarth</surname>, <given-names>P</given-names></string-name>., <string-name><surname>Esteves</surname>, <given-names>P</given-names></string-name>., <string-name><surname>Blervaque</surname>, <given-names>L</given-names></string-name>., <string-name><surname>Zysman</surname>, <given-names>M</given-names></string-name>. <etal>et al</etal></person-group>., <year>2023</year>, &#x2018;<article-title>Main pathogenic mechanisms and recent advances in COPD peripheral skeletal muscle wasting</article-title>&#x2019;, <source><italic>International Journal of Molecular Sciences</italic></source> <volume>24</volume>(<issue>7</issue>), <fpage>6454</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijms24076454">https://doi.org/10.3390/ijms24076454</ext-link></comment></mixed-citation></ref>
<ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Houben-Wilke</surname>, <given-names>S</given-names></string-name>., <string-name><surname>Spruit</surname>, <given-names>M.A</given-names></string-name>., <string-name><surname>Uszko-Lencer</surname>, <given-names>N.H</given-names></string-name>., <string-name><surname>Otkinska</surname>, <given-names>G</given-names></string-name>., <string-name><surname>Vanfleteren</surname>, <given-names>L.E</given-names></string-name>., <string-name><surname>Jones</surname>, <given-names>P.W</given-names></string-name>. <etal>et al</etal></person-group>., <year>2017</year>, &#x2018;<article-title>Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation</article-title>&#x2019;, <source><italic>Respirology</italic></source> <volume>22</volume>(<issue>5</issue>), <fpage>928</fpage>&#x2013;<lpage>934</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/resp.12968">https://doi.org/10.1111/resp.12968</ext-link></comment></mixed-citation></ref>
<ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hsieh</surname>, <given-names>M.J</given-names></string-name>., <string-name><surname>Yang</surname>, <given-names>T.M</given-names></string-name>. &#x0026; <string-name><surname>Tsai</surname>, <given-names>Y.H</given-names></string-name></person-group>., <year>2016</year>, &#x2018;<article-title>Nutritional supplementation in patients with chronic obstructive pulmonary disease</article-title>&#x2019;, <source><italic>Journal of the Formosan Medical Association</italic></source> <volume>115</volume>(<issue>8</issue>), <fpage>595</fpage>&#x2013;<lpage>601</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jfma.2015.10.008">https://doi.org/10.1016/j.jfma.2015.10.008</ext-link></comment></mixed-citation></ref>
<ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hurst</surname>, <given-names>J.R</given-names></string-name>., <string-name><surname>Skolnik</surname>, <given-names>N</given-names></string-name>., <string-name><surname>Hansen</surname>, <given-names>G.J</given-names></string-name>., <string-name><surname>Anzueto</surname>, <given-names>A</given-names></string-name>., <string-name><surname>Donaldson</surname>, <given-names>G.C</given-names></string-name>., <string-name><surname>Dransfield</surname>, <given-names>M.T</given-names></string-name>. <etal>et al</etal></person-group>., <year>2020</year>, &#x2018;<article-title>Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life</article-title>&#x2019;, <source><italic>European Journal of Internal Medicine</italic></source> <volume>73</volume>, <fpage>1</fpage>&#x2013;<lpage>6</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejim.2019.12.014">https://doi.org/10.1016/j.ejim.2019.12.014</ext-link></comment></mixed-citation></ref>
<ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jones</surname>, <given-names>P.W</given-names></string-name>., <string-name><surname>Harding</surname>, <given-names>G</given-names></string-name>., <string-name><surname>Berry</surname>, <given-names>P</given-names></string-name>., <string-name><surname>Wiklund</surname>, <given-names>I</given-names></string-name>., <string-name><surname>Chen</surname>, <given-names>W.H</given-names></string-name>. &#x0026; <string-name><surname>Leidy</surname>, <given-names>N.K</given-names></string-name></person-group>., <year>2009</year>, &#x2018;<article-title>Development and first validation of the COPD Assessment Test</article-title>&#x2019;, <source><italic>European Respiratory Journal</italic></source> <volume>34</volume>(<issue>3</issue>), <fpage>648</fpage>&#x2013;<lpage>654</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1183/09031936.00102509">https://doi.org/10.1183/09031936.00102509</ext-link></comment></mixed-citation></ref>
<ref id="CIT0021"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Junita</surname>, <given-names>I.M</given-names></string-name>., <string-name><surname>Zulfikar</surname>, <given-names>T</given-names></string-name>., <string-name><surname>Yusuf</surname>, <given-names>N</given-names></string-name>., <string-name><surname>Azhary</surname>, <given-names>M</given-names></string-name>. &#x0026; <string-name><surname>Salim</surname>, <given-names>H.M</given-names></string-name></person-group>., <year>2022</year>, &#x2018;<article-title>The effect of pursed-lips breathing and diaphragm exercises on the quality of life of COPD patient assessed by six-minutes walk test</article-title>&#x2019;, <source><italic>Bali Medical Journal</italic></source> <volume>11</volume>(<issue>3</issue>), <fpage>1116</fpage>&#x2013;<lpage>1120</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15562/bmj.v11i3.3474">https://doi.org/10.15562/bmj.v11i3.3474</ext-link></comment></mixed-citation></ref>
<ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lan</surname>, <given-names>C.C</given-names></string-name>., <string-name><surname>Yang</surname>, <given-names>M.C</given-names></string-name>., <string-name><surname>Huang</surname>, <given-names>H.C</given-names></string-name>., <string-name><surname>Wu</surname>, <given-names>C.W</given-names></string-name>., <string-name><surname>Su</surname>, <given-names>W.L</given-names></string-name>., <string-name><surname>Tzeng</surname>, <given-names>I.S</given-names></string-name>. <etal>et al</etal></person-group>., <year>2018</year>, &#x2018;<article-title>Serial changes in exercise capacity, quality of life and cardiopulmonary responses after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease</article-title>&#x2019;, <source><italic>Heart &#x0026; Lung</italic></source> <volume>47</volume>(<issue>5</issue>), <fpage>477</fpage>&#x2013;<lpage>484</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.hrtlng.2018.06.006">https://doi.org/10.1016/j.hrtlng.2018.06.006</ext-link></comment></mixed-citation></ref>
<ref id="CIT0023"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leite</surname>, <given-names>M.R</given-names></string-name>., <string-name><surname>Ramos</surname>, <given-names>E.M.C</given-names></string-name>., <string-name><surname>Kalva-Filho</surname>, <given-names>C.A</given-names></string-name>., <string-name><surname>Freire</surname>, <given-names>A.P.C.F</given-names></string-name>., <string-name><surname>De Alencar Silva</surname>, <given-names>B.S</given-names></string-name>., <string-name><surname>Nicolino</surname>, <given-names>J</given-names></string-name>. <etal>et al</etal></person-group>., <year>2015</year>, &#x2018;<article-title>Effects of 12 weeks of aerobic training on autonomic modulation, mucociliary clearance, and aerobic parameters in patients with COPD</article-title>&#x2019;, <source><italic>International Journal of Chronic Obstructive Pulmonary Disease</italic></source> <volume>10</volume>, <fpage>2549</fpage>&#x2013;<lpage>2557</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2147/COPD.S81363">https://doi.org/10.2147/COPD.S81363</ext-link></comment></mixed-citation></ref>
<ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>W</given-names></string-name>., <string-name><surname>Pu</surname>, <given-names>Y</given-names></string-name>., <string-name><surname>Meng</surname>, <given-names>A</given-names></string-name>., <string-name><surname>Zhi</surname>, <given-names>X</given-names></string-name>. &#x0026; <string-name><surname>Xu</surname>, <given-names>G</given-names></string-name></person-group>., <year>2019</year>, &#x2018;<article-title>Effectiveness of pulmonary rehabilitation in elderly patients with COPD: A systematic review and meta-analysis of randomized controlled trials</article-title>&#x2019;, <source><italic>International Journal of Nursing Practice</italic></source> <volume>25</volume>(<issue>5</issue>), <fpage>e12745</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/ijn.12745">https://doi.org/10.1111/ijn.12745</ext-link></comment></mixed-citation></ref>
<ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Malaguti</surname>, <given-names>C</given-names></string-name>., <string-name><surname>Dal Corso</surname>, <given-names>S</given-names></string-name>., <string-name><surname>Janjua</surname>, <given-names>S</given-names></string-name>. &#x0026; <string-name><surname>Holland</surname>, <given-names>A.E</given-names></string-name></person-group>., <year>2021</year>, &#x2018;<article-title>Supervised maintenance programmes following pulmonary rehabilitation compared to usual care for chronic obstructive pulmonary disease</article-title>&#x2019;, <source><italic>Cochrane Database of Systematic Reviews</italic></source> (<issue>8</issue>)<volume>8</volume>, <fpage>CD013569</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/14651858.cd013569.pub2">https://doi.org/10.1002/14651858.cd013569.pub2</ext-link></comment></mixed-citation></ref>
<ref id="CIT0026"><mixed-citation publication-type="web"><person-group person-group-type="author"><string-name><surname>Meshe</surname>, <given-names>O.F</given-names></string-name></person-group>., <year>2023</year>, &#x2018;<article-title>Physical activity, health status and hospital admission in chronic obstructive pulmonary disease following pulmonary rehabilitation</article-title>&#x2019;, <month>Anglia Ruskin Research Online (ARRO)</month>, <comment>Thesis, viewed from <ext-link ext-link-type="uri" xlink:href="https://hdl.handle.net/10779/aru.23761557.v1">https://hdl.handle.net/10779/aru.23761557.v1</ext-link>.</comment></mixed-citation></ref>
<ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ramos</surname>, <given-names>M</given-names></string-name>., <string-name><surname>Lamotte</surname>, <given-names>M</given-names></string-name>., <string-name><surname>Gerlier</surname>, <given-names>L</given-names></string-name>., <string-name><surname>Svangren</surname>, <given-names>P</given-names></string-name>., <string-name><surname>Miquel-Cases</surname>, <given-names>A</given-names></string-name>. &#x0026; <string-name><surname>Haughney</surname>, <given-names>J</given-names></string-name></person-group>., <year>2019</year>, &#x2018;<article-title>Cost-effectiveness of physical activity in the management of COPD patients in the UK</article-title>&#x2019;, <source><italic>International Journal of Chronic Obstructive Pulmonary Disease</italic></source> <volume>14</volume>, <fpage>227</fpage>&#x2013;<lpage>239</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2147/COPD.S181194">https://doi.org/10.2147/COPD.S181194</ext-link></comment></mixed-citation></ref>
<ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rochester</surname>, <given-names>C.L</given-names></string-name>., <string-name><surname>Vogiatzis</surname>, <given-names>I</given-names></string-name>., <string-name><surname>Holland</surname>, <given-names>A.E</given-names></string-name>., <string-name><surname>Lareau</surname>, <given-names>S.C</given-names></string-name>., <string-name><surname>Marciniuk</surname>, <given-names>D.D</given-names></string-name>., <string-name><surname>Puhan</surname>, <given-names>M.A</given-names></string-name>. <etal>et al</etal></person-group>., <year>2015</year>, &#x2018;<article-title>An official American Thoracic Society/European Respiratory Society policy statement: Enhancing implementation, use, and delivery of pulmonary rehabilitation</article-title>&#x2019;, <source><italic>American Journal of Respiratory and Critical Care Medicine</italic></source> <volume>192</volume>(<issue>11</issue>), <fpage>1373</fpage>&#x2013;<lpage>1386</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1164/rccm.201510-1966ST">https://doi.org/10.1164/rccm.201510-1966ST</ext-link></comment></mixed-citation></ref>
<ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sciurba</surname>, <given-names>F.C</given-names></string-name>. &#x0026; <string-name><surname>Slivka</surname>, <given-names>W.A</given-names></string-name></person-group>., <year>1998</year>, &#x2018;<article-title>Six-minute walk testing</article-title>&#x2019;, <source><italic>Seminars in Respiratory and Critical Care Medicine</italic></source> <volume>19</volume>(<issue>4</issue>), <fpage>383</fpage>&#x2013;<lpage>92</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1055/s-2007-1009125">https://doi.org/10.1055/s-2007-1009125</ext-link></comment></mixed-citation></ref>
<ref id="CIT0030"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shu</surname>, <given-names>C.C</given-names></string-name>., <string-name><surname>Lee</surname>, <given-names>J.H</given-names></string-name>., <string-name><surname>Tsai</surname>, <given-names>M.K</given-names></string-name>., <string-name><surname>Su</surname>, <given-names>T.C</given-names></string-name>. &#x0026; <string-name><surname>Wen</surname>, <given-names>C.P</given-names></string-name></person-group>., <year>2021</year>, &#x2018;<article-title>The ability of physical activity in reducing mortality risks and cardiovascular loading and in extending life expectancy in patients with COPD</article-title>&#x2019;, <source><italic>Scientific Reports</italic></source> <volume>11</volume>(<issue>1</issue>), <fpage>21674</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41598-021-00728-2">https://doi.org/10.1038/s41598-021-00728-2</ext-link></comment></mixed-citation></ref>
<ref id="CIT0031"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Spielmanns</surname>, <given-names>M</given-names></string-name>., <string-name><surname>Schulze</surname>, <given-names>S.T</given-names></string-name>., <string-name><surname>Guenes</surname>, <given-names>E</given-names></string-name>., <string-name><surname>Pekacka-Falkowska</surname>, <given-names>K</given-names></string-name>., <string-name><surname>Windisch</surname>, <given-names>W</given-names></string-name>. &#x0026; <string-name><surname>Pekacka-Egli</surname>, <given-names>A.M</given-names></string-name></person-group>., <year>2023</year>, &#x2018;<article-title>Clinical effects of pulmonary rehabilitation in very old patients with COPD</article-title>&#x2019;, <source><italic>Journal of Clinical Medicine</italic></source> <volume>12</volume>(<issue>7</issue>), <fpage>2513</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/jcm12072513">https://doi.org/10.3390/jcm12072513</ext-link></comment></mixed-citation></ref>
<ref id="CIT0032"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tachkov</surname>, <given-names>K</given-names></string-name>., <string-name><surname>Kamusheva</surname>, <given-names>M</given-names></string-name>., <string-name><surname>Pencheva</surname>, <given-names>V</given-names></string-name>. &#x0026; <string-name><surname>Mitov</surname>, <given-names>K</given-names></string-name></person-group>., <year>2017</year>, &#x2018;<article-title>Evaluation of the economic and social burden of chronic obstructive pulmonary disease (COPD)</article-title>&#x2019;, <source><italic>Biotechnology &#x0026; Biotechnological Equipment</italic></source> <volume>31</volume>(<issue>4</issue>), <fpage>855</fpage>&#x2013;<lpage>861</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/13102818.2017.1335616">https://doi.org/10.1080/13102818.2017.1335616</ext-link></comment></mixed-citation></ref>
<ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Venkatesan</surname>, <given-names>P</given-names></string-name></person-group>., <year>2024</year>, &#x2018;<article-title>GOLD COPD report: 2024 update</article-title>&#x2019;, <source><italic>Lancet Respiratory Medicine</italic></source> <volume>12</volume>(<issue>1</issue>), <fpage>15</fpage>&#x2013;<lpage>16</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2213-2600(23)00461-7">https://doi.org/10.1016/S2213-2600(23)00461-7</ext-link></comment></mixed-citation></ref>
<ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yohannes</surname>, <given-names>A.M</given-names></string-name>., <string-name><surname>Dryden</surname>, <given-names>S</given-names></string-name>., <string-name><surname>Casaburi</surname>, <given-names>R</given-names></string-name>., &#x0026; <string-name><surname>Hanania</surname>, <given-names>N.A</given-names></string-name></person-group>., <year>2021</year>, &#x2018;<article-title>Long-term benefits of pulmonary rehabilitation in patients with COPD: A 2-year follow-up study</article-title>&#x2019;, <source><italic>Chest</italic></source> <volume>159</volume>, <fpage>967</fpage>&#x2013;<lpage>74</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chest.2020.10.061">https://doi.org/10.1016/j.chest.2020.10.061</ext-link></comment></mixed-citation></ref>
</ref-list>
<fn-group>
<fn><p>Republication: 05 Feb. 2026</p></fn>
<fn><p><bold>How to cite this article:</bold> Sabah, H.A.E., Mohammed, R. &#x0026; Rashad, S.M., 2026, &#x2018;Pulmonary rehabilitation in severe chronic obstructive pulmonary disease: Is there any benefit?&#x2019;, <italic>African Journal of Disability</italic> 15(0), a1766. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4102/ajod.v15i0.1766">https://doi.org/10.4102/ajod.v15i0.1766</ext-link></p></fn>
<fn><p><bold>Note:</bold> This article was republished with an updated DOI and QR code. This correction does not alter the study&#x2019;s findings of significance or overall interpretation of the study&#x2019;s results. The publisher apologises for any inconvenience caused.</p></fn>
</fn-group>
</back>
</article>